BAC BV – The Affinity Experts, now part of Life Technologies
BAC discovers,develops and manufactures separation and affinity purification products for use across the value chain of biopharmaceutical R&D and manufacturing. Based on BAC’s proprietary single-chain antibody technology called CaptureSelect®, the products are suitable for the discovery, preclinical and clinical manufacturing of therapeutic proteins, including antibodies and antibody fragments.
Check out lifetechnologies.com/captureselect for more information.
BAC BV became part of Life Technologies Corporation in January 2013. This page is not being frequently updated and we encourage you to follow us on the Life Technologies LinkedIn page, on Facebook (facebook/bioproduction) and Twitter (twitter.com/molecule2market) for industry and product updates.